Double-hit vitreoretinal lymphoma

Can J Ophthalmol. 2014 Jun;49(3):e73-6. doi: 10.1016/j.jcjo.2014.03.012.

Authors

Chris Or¹, Andrew W Kirker¹, Steve Rasmussen¹, Diego Villa², Alina S Gerrie³, Farzin Forooghian⁴

Affiliations

¹ University of British Columbia.
² Centre for Lymphoid Cancer, British Columbia Cancer Agency.
³ Centre for Lymphoid Cancer, British Columbia Cancer Agency; Leukemia/Bone Marrow Transplantation Program of British Columbia, Vancouver, B.C.
⁴ University of British Columbia. Electronic address: farzin.forooghian@gmail.com.

PMID: 24862789
DOI: 10.1016/j.jcjo.2014.03.012

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Chromosomes, Human, Pair 14 / genetics
Chromosomes, Human, Pair 18 / genetics
Chromosomes, Human, Pair 8 / genetics
Eye Neoplasms / diagnosis
Eye Neoplasms / drug therapy
Eye Neoplasms / genetics
Humans
Immunoglobulin Heavy Chains / genetics
Lymphoma, Large B-Cell, Diffuse / diagnosis
Lymphoma, Large B-Cell, Diffuse / drug therapy
Lymphoma, Large B-Cell, Diffuse / genetics*
Male
Proto-Oncogene Proteins c-bcl-2 / genetics*
Proto-Oncogene Proteins c-myc / genetics*
Retinal Neoplasms / diagnosis
Retinal Neoplasms / drug therapy
Retinal Neoplasms / genetics*
Tomography, Optical Coherence
Translocation, Genetic*
Visual Acuity
Vitreous Body / pathology*

Substances

Immunoglobulin Heavy Chains
Proto-Oncogene Proteins c-bcl-2
Proto-Oncogene Proteins c-myc